Integer Holdings (ITGR) Cash from Investing Activities (2010 - 2026)
Integer Holdings (ITGR) reported Cash from Investing Activities of -$37.9 million for Q2 2026, up 80.78% on a YoY basis from -$21.0 million in Q2 2025, and down 6.86% sequentially from -$35.5 million in Q4 2025.
Integer Holdings (ITGR) Cash from Investing Activities (2010 - 2026) Analysis & Trends
Integer Holdings (ITGR) has 17 years of Cash from Investing Activities data on file, last reported at -$37.9 million in Q2 2026.
- For the quarter ending Q2 2026, Cash from Investing Activities rose 80.78% year-over-year to -$37.9 million; the trailing twelve-month figure through Apr 2026 stood at -$111.5 million (up 50.32% YoY), and the FY2025 full-year result was -$270.7 million, down 38.54% from the prior year.
- Cash from Investing Activities retreated to -$37.9 million in Q2 2026, from -$35.5 million in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $29.6 million in Q4 2024 to a low of -$197.2 million in Q1 2025.
- A 5-year average of -$51.0 million and a median of -$30.6 million in 2024 frame the typical range for Cash from Investing Activities.
- Across the five-year window, Cash from Investing Activities tumbled 1185.43% in 2022 and surged 136.75% in 2024, its largest moves.
- Tracing ITGR's Cash from Investing Activities over 5 years: stood at -$31.3 million in 2022, then sank by 157.26% to -$80.6 million in 2023, then jumped by 136.75% to $29.6 million in 2024, then sank by 219.76% to -$35.5 million in 2025, then decreased by 6.86% to -$37.9 million in 2026.
- Business Quant data shows ITGR's Cash from Investing Activities at -$37.9 million in Q2 2026, -$35.5 million in Q4 2025, and -$20.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -92.80 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -298.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -475.32 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -2.50 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Integer Holdings | 3.34 Bn | 3.33 Bn | 109.60 Mn | -37.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | -37.90 Mn |
| Apr 3, 2026 | -37.90 Mn |
| Dec 31, 2025 | -35.47 Mn |
| Dec 31, 2025 | -35.47 Mn |
| Sep 26, 2025 | -20.27 Mn |
| Sep 26, 2025 | -20.27 Mn |
| Jun 27, 2025 | -17.83 Mn |
| Jun 27, 2025 | -17.83 Mn |
| Mar 28, 2025 | -197.17 Mn |
| Mar 28, 2025 | -197.17 Mn |
| Dec 31, 2024 | 29.62 Mn |
| Dec 31, 2024 | 29.62 Mn |
| Sep 27, 2024 | -26.24 Mn |
| Sep 27, 2024 | -26.24 Mn |
| Jun 28, 2024 | -30.60 Mn |
| Jun 28, 2024 | -30.60 Mn |
| Mar 29, 2024 | -168.20 Mn |
| Mar 29, 2024 | -168.20 Mn |
| Dec 31, 2023 | -80.58 Mn |
| Dec 31, 2023 | -80.58 Mn |